期刊文献+

肺鳞癌组织Hsa-mir-182差异表达的研究 被引量:5

Different expression of Hsa-mir-182 in lung squamous cell carcinoma tissues
原文传递
导出
摘要 目的:寻找肺鳞状细胞癌组织中与正常组织中差异表达的微小RNA(miRNA),并对其进行生物学功能的预测及验证。方法:应用芯片技术筛选30例肺鳞癌组织中与正常组织中差异表达的miRNA。选取差异表达的mir-182家族进行定量PCR验证,通过生物信息学网站预测其靶基因,并在体外进行荧光素酶报告基因验证。结果:Hsa-mir-182家族在肺鳞癌组织中表达丰度较正常组织明显升高。生物信息学网站预测发现,RASA1可能是mir-182的靶基因。体外过表达mir-182后,发现RASA1表达量显著下降,验证了RASA1确实为mir-182的靶基因。结论:Hsa-mir-182家族在肺鳞癌组织中显著高表达,而且RASA1基因系mir-182的靶基因。 OBJECTIVE:To detect the different expression of microRNA (miRNA) in lung squamous cell cancer and to predict and validate their biological function. MEI^Ol~:Microarray was used to discover the special miRNA which was differentially ex- pressed between lung squamous cell cancer tissues and normal lung tissues. The mir-182 family which was significantly upregulated in lung squamous cell cancer tissues were tested through qualitative PCR. The target genes were predicted by public algorithms and con- firmed in v/vo. RESULTS: Hsa-mir-182 family was highly expressed in lung squamous cell carcinoma. After mir-182 being overex- pressed,the expression of RASA1 was significantly down regulated, which further confirmed that RASA1 was the target gene of mir-182. CONCLUSIONS:Hsa-rnir-182 family is significantly high expressed in lung squamous cell cancer. Mir-182 downregulates RASA1 and it may play an important role in lung squamous cell cancer.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第16期1225-1228,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 MICRORNA Hsa-mir-182 肺鳞癌 基因表达 microRNA Hsa-mir-182 lung squamous cell cancer gene expression
  • 相关文献

参考文献13

  • 1Liu X,Sempere L F,Ouyang H,et al. MicroRNA-31 functions asan oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors[J]. J Clin Invest, 2010, 120(4) : 1298q309.
  • 2Croce CM. Causes and consequences of microRNA dysregulation in cancer[J] Nat Rev Genet, 2009,10 (10) : 704-714.
  • 3Bishop JA,Benjamin H,Cholakh H,et ah Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approaeh[J]. Clin Cancer Res, 2010,16 (2) : 610-619.
  • 4Raponi M, Dossey L, Jatkoe T, et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer[J]. Cancer Res,2009,69(14) :5776-5783.
  • 5Sarver AL,French AJ,Borralho PM, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states[J]. BMC Cancer, 2009,9 : 401-416.
  • 6Guttilla IK,White BA. Coordinate regulation of FOXO1 by miR- 27a, miR-96, and miR-182 in breast cancer cells[J]. J Biol Chem,2009,284(35) :23204-23216.
  • 7Jiang L, Mao P, Song L, et al. miR-182 as a prognostic marker for glioma progression and patient survival[J]. Am J Pathol, 2010,177 (1) : 29-38.
  • 8Sacheli R, Nguyen L, Borgs L, et al. Expression patterns of miR- 96,miR-182 and miR-183 in the development inner ear[J]. Gene Expr Patterns, 2009,9 (5) : 364-370.
  • 9Segura MF, Hanniford D, Menendez S,et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor[J]. Proc Natl Acad Sci U S A,2009,106(6):1814-1819.
  • 10Sun Y,Fang R,Li C,et al. Hsa-mir-182 suppresses lung tumori- genesis through down regulation of RGS17 expression in vitro [J]. Biochem Biophys Res Commun,2010,396(2) : 501-507.

同被引文献39

  • 1Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels[J]. Nature, 2010,466 (738) : 835-840.
  • 2Lujambio A, Lowe SW. The mierocosmos of cancer[J]. Nature,2012,482(7385) :347 -355.
  • 3Yang X,Feng M,Jiang X,et al. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A [J]. Genes Dev, 2009, 23 (20) : 2388-2393.
  • 4Cho WC, Chow AS, Au JS. Restoration of tumour sup pressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor re- ceptor mutation[J]. Eur J Cancer, 2009,45 (12) : 2197 -2206.
  • 5Duan W,Gao L,Wu X,et al. MicroRNA-34a is an impor- tant component of PRIMA-l-induced apoptotie network in human lung cancer cells[J]. Int J Cancer, 2010,127 (2): 313-320.
  • 6Incoronato M,GarofaIo M, Urso L, et al. miR212 increa ses tumor necrosis factor-related apoptosis-inducing lig- and sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED [ J ]. Cancer Res, 2010, 70 (9) : 3638-3646.
  • 7Guo H, Ingolia NT, Weissman JS, et al. Mammalian mieroRNAs pre- dominantly act to decrease larget mRNA levels [ J ]. Nature, 2010, 466 ( 7308 ) : 835 - 840.
  • 8Lujambio A, Lowe SW. The microcosmos of cancer [J]. Nature, 2012, 482(7385): 347 -355.
  • 9Yang X, Feng M, Jiang X, el al. MiRNA-449a and miRNA -449h are direct transcriplional targets of E2F1 and negatively regulate pRb - E2F1 actively through a feedback loop by targeting CDK6 and CDC25A [J]. Genes Dev, 2009, 23(20): 2388-2393.
  • 10Cho WC, Chow AS, Au JS. Restoration of tumor suppressor has - miR - 14-5 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation [ J ]. Eur J Cancer, 2009, 45:2197 - 2206.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部